Seal Colour Coding in Pharma: What the Convention Is and What It Is Not

A row of vials with flip-off seals in a range of different button colours

Seal colour coding in pharma is a house convention: the company that holds the marketing authorisation gives a product, strength or formulation its own cap colour so staff can tell vials apart at a glance. It is not a universal code, and it is not standardised across markets, so a blue flip-off cap means whatever that company’s scheme says and nothing more. A handful of rules reserve particular cap colours or cap markings in particular markets, and US FDA guidance generally recommends avoiding colour coding in most instances. The printed label identifies the product; the cap colour only helps people find it.

This guide sets out what the convention is, what it is not, where it differs between markets, how to build a scheme that holds up in more than one market, and where colour stops being a safeguard.

Key takeaways

A seal colour is an identification aid inside one company’s scheme, used to separate products, strengths or formulations.
No global standard assigns a meaning to a vial seal colour, and the same colour means different things from different manufacturers.
Colour coding is not standardised across markets. A scheme that works in one country or hospital system carries no meaning in another.
Some rules do reserve colours or markings: in the US, a black cap overseal and ferrule are used only for concentrated potassium chloride, and the top of the cap is kept for cautionary statements.
US FDA guidance generally recommends avoiding colour coding and separates it from colour differentiation, which it treats as useful.
A seal colour says nothing about sterility, integrity or tamper status, and it is not the blood-tube colour code.
Autofits reproduces the colour a customer specifies and does not assign meanings to colours; the range is on the by-colour page.

What the convention is

The convention is a set of colour rules that one company defines and applies across its own range, so that inside that range a colour reliably points to one product or one strength. Its value comes from consistency within the range, not from agreement with anyone else’s colours.

The coloured polypropylene disc on a flip-off seal is well suited to the job because it is the most visible part of a vial standing in a tray, and it can be moulded in almost any colour. The aluminium can carry colour too, through pigmented lacquer. Companies use those two surfaces in a few recurring ways:

One colour per product, so adjacent vials of different drugs look different before the label is read.
A strength ladder, where each strength of one drug gets its own colour and the higher and lower doses are visibly separated, the pattern familiar from insulin and hormone ranges.
One colour per formulation or presentation, for example separating a preservative-free presentation from a standard one.
A house colour, where a family identity carries across neck sizes and the colour does brand work rather than safety work.

The stakes are highest where a wrong pick is hard to recover from and made in seconds, such as cytotoxic oncology vials, anaesthetic agents and the look-alike strengths stocked for emergency drugs on a crash cart. The colour is a communication layer on top of the closure. The sealing itself is done by the aluminium crimp and the stopper, as explained in how flip-off caps work.

What the convention is not

Most confusion about cap colours comes from reading a house convention as though it were a public code. Six things a seal colour is often taken to be, and is not:

A seal colour is not	Why
A universal code	No global standard assigns meanings to vial seal colours, so the same colour means different things across manufacturers
An identifier of the drug	The printed vial and carton label identify the product; colour only supports finding it
The same in every market	Rules and hospital conventions differ between countries, and some rules reserve a specific colour
The blood-tube colour code	Coloured stoppers on blood collection tubes identify the additive in a laboratory sample tube, a separate convention
The ophthalmic cap convention	US eye-care products colour-code bottle caps by therapeutic class; that convention belongs to ophthalmic bottles, not injectable vial seals
A sign of sterility, integrity or tamper status	Those come from the crimp, the stopper and the tamper-evident design, whatever the colour

In practice, a pharmacist, nurse or line operator who meets an unfamiliar product cannot infer anything from its cap colour, and a buyer specifying a seal cannot look up “the right colour” for a drug. The colour is whatever the marketing-authorisation holder chose.

Colour coding is not standardised across markets

The caution matters most for anyone selling one product into several countries: outside a few specific rules, cap colour is a company choice, and no market’s convention carries over to another automatically.

The clearest published position comes from the US. The FDA’s May 2022 guidance, Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors, says FDA generally recommends avoiding colour coding in most instances, reserving it for special circumstances or for cases supported by human factors data. It gives four reasons colour misleads: people perceive colours differently and some have colour vision deficiency, identification by colour can replace reading the label, only a limited number of colours can be told apart, and colours look different under different lighting. It also notes that a colour code is not meaningful to users outside the setting where it has an established use.

The same guidance records the rules that do fix colours or markings on vial closures in the US, drawing on USP General Chapter <7>, Labeling:

Black is reserved. A black closure system on a vial, meaning a black cap overseal and a black ferrule, is used only for Potassium Chloride for Injection Concentrate, to mark the concentrated strength. Black caps should not be used on any other drug product.
The top of the cap is reserved for warnings. Information on the ferrule and cap overseal is limited to cautionary statements that prevent imminent life-threatening situations. Where no cautionary statement is required, the top surface stays blank.
Some products must carry a warning there. Injectable neuromuscular blocking agents are packaged in vials with a cautionary statement printed on the ferrules and cap overseals.

These are US rules for products sold in the US. Outside rules like these, colour is left to the marketing-authorisation holder, which is why the same molecule can carry different cap colours from different manufacturers, and why an export range should check the destination market’s labelling requirements before it carries a domestic colour scheme across.

Colour differentiation and colour coding are different things

FDA separates using colour to make products look different from using colour to carry a fixed meaning, and supports the first far more readily than the second.

Colour differentiation means giving products or strengths within a range visibly different colours so they are not confused with each other. The guidance describes it as a tool that may help differentiate products and strengths within a manufacturer’s line and draw attention to warnings. Colour coding means a colour stands for something specific, such as a therapeutic class, and users are expected to know the key. That is where errors arise, because the key only works for people inside the setting that learned it.

For a vial seal specification, this distinction is the useful one. Using cap colour to keep a 1 g vial from looking like a 2 g vial of the same drug is differentiation, and it holds up. Choosing a cap colour because “this class of drug is usually red” is coding, and it assumes a shared key that does not exist across markets.

Building a scheme that holds up in more than one market

A colour scheme survives export when it relies on contrast inside the range, avoids reserved colours and surfaces, and never makes colour the only cue.

Separate neighbours, not everything. Put the strongest contrast between strengths that sit next to each other, since those are the pairs that get confused.
Check every destination market for reserved colours. Black is the documented case for the US; confirm the others before finalising.
Keep the cap top clear where it is reserved. If a market limits the top of the ferrule and cap overseal to cautionary statements, put batch or brand marks elsewhere.
Pair colour with print or emboss. A strength printed or embossed on the disc still works for someone who cannot tell two colours apart.
Test under real lighting. A shade that is distinct under studio light can merge under a pharmacy’s fluorescent tubes or a ward’s night lighting.
Write the scheme into the component specification. Record the colour references against each product and strength, and put a colour change under change control like any other component change.
Hold the scheme across neck sizes. If a product runs on 13 mm and 20 mm vials, the same strength should carry the same colour on both.

The limits of relying on seal colour

Seal colour is a useful cue and a weak safeguard, because it has no cross-industry meaning and can be misread.

It can be confused. Similar shades under different lighting look alike, especially in a hurry.
It can be relied on instead of the label. That shortcut is the main way a colour scheme causes the error it was meant to prevent.
It says nothing about the closure’s condition. A correctly coloured seal can still be under-crimped or opened; colour does not indicate integrity or tamper status.

Used as a consistent, documented aid within one company’s range and always alongside the label, colour reduces selection errors. Used as a shortcut to skip reading the label, it adds risk.

How this works in practice at Autofits

Autofits produces the coloured seals that carry a customer’s scheme and treats colour as a made-to-requirement attribute rather than a catalogue legend. The FlipTop Optima flip-off seals are available in a wide range of colours, matte or glossy, customised to the customer’s requirement, and the aluminium and the disc can be printed and embossed to carry a strength or an instruction as well as a colour. Colour comes from the moulded polypropylene disc and from pigmented epoxy lacquer on the AA8011 aluminium, so it is built into the components rather than applied afterwards; the lacquer, print and emboss options are compared in aluminium cap finish types.

Because there is no universal colour legend, Autofits does not assign meanings to colours. The customer specifies the colour for each product and strength, and Autofits reproduces it consistently under 100% high-speed camera inspection and an ISO 15378:2017 quality system. The colour range by product line is on the by-colour page, matching a specific shade is covered on the vial seal colour chart, and bespoke colour and print work is described in custom vial seal manufacturing.

Frequently asked questions

What does the colour of a vial seal mean?

A vial seal colour means whatever the product’s manufacturer decided it means within its own range, usually a particular product, strength or formulation. There is no universal legend, so the same colour can mean different things from different companies. The colour helps staff find the right vial quickly, and the printed label is what identifies it.

Is there a legal standard for pharma seal colours?

There is no global legal standard that assigns a meaning to each vial seal colour. Some markets have specific rules for specific products; in the US, for example, a black cap overseal and ferrule are reserved for Potassium Chloride for Injection Concentrate. Outside rules like that, colour is set by the marketing-authorisation holder.

Is seal colour coding the same in every country?

No. Colour coding is not standardised across markets. A scheme used by one manufacturer, hospital system or country has no meaning elsewhere unless a local rule applies, so a product sold in several markets should have its colours checked against each market’s labelling requirements.

Which cap colour is reserved for potassium chloride?

In the US, a black closure system, meaning a black cap overseal and a black ferrule, is used only for Potassium Chloride for Injection Concentrate, following USP General Chapter <7>, Labeling. The colour marks the concentrated strength, and black caps should not be used on any other drug product sold there.

Can you identify a drug by its cap colour alone?

No. Cap colour has no fixed meaning across manufacturers, similar shades are easily confused, and some people have colour vision deficiency. The printed vial and carton label is the definitive identifier, and colour only supports finding the right vial within one company’s documented scheme.

Does the seal colour affect how the seal works?

No. Colour comes from the plastic disc and, when pigmented, the lacquer on the aluminium. It does not change the seal’s materials, fit, integrity or tamper-evidence behaviour. The sealing function comes from the aluminium crimp holding the rubber stopper compressed against the glass.

Sources

U.S. FDA: Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors, Guidance for Industry, May 2022 (https://www.fda.gov/media/158522/download)
USP-NF: General Chapter <7>, Labeling, section on Ferrules and Cap Overseals (https://www.uspnf.com/)
ISMP (Institute for Safe Medication Practices): guidance on label and packaging design and look-alike risk (https://www.ismp.org/)
ISO: ISO 8362-6:2010, Injection containers and accessories, Part 6: Caps made of aluminium-plastics combinations for injection vials (https://www.iso.org/standard/52806.html)

*Last updated: 2026-09-15. This article is general technical information, not regulatory or compliance advice; confirm current labelling requirements for each market with the relevant authority.*